Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

GSK, with its diversified portfolio, therefore reaches more physicians than any other company in the market. "GSK maintains a relatively large field force, reaching the majority of physicians in a ...

NEW YORK CITY, NY / ACCESS Newswire / April 4, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...

By Blake Brittain (Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that ...

GSK PLC closed 21.39% short of its 52-week high of £18.24, which the company reached on May 16th.

GSK PLC closed 18.56% short of its 52-week high of £18.24, which the company achieved on May 16th.

The drug is a needed new option for treating uncomplicated UTIs, a common infection that’s becoming harder to treat as rates ...